Clonidine in Attention Deficit Hyperactivity Disorder (ADHD) in Children
Status:
Completed
Trial end date:
2007-06-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine the safety and efficacy of clonidine alone or in
combination with methylphenidate for children 7-12 years of age with attention-deficit,
hyperactivity disorder.
Phase:
Phase 3
Details
Lead Sponsor:
University of Cincinnati
Collaborator:
National Institute of Neurological Disorders and Stroke (NINDS)